文献速递贫血与红细胞疾病

在电子健康记录中识别血红蛋白SS/Sβ0地中海贫血病患者及疼痛危象

Identification of patients with hemoglobin SS/Sβ0 thalassemia disease and pain crises within electronic health records.
PubMed 文献 · Blood Adv · 2018-01-01

研究利用2013至2016年威斯康星儿童医院360名镰状细胞病患儿的电子健康记录数据,验证基于诊断编码、血液检查及经颅多普勒等复合信息识别血红蛋白SS/Sβ0地中海贫血基因型及急性疼痛就诊的算法,以本地登记库和病历为金标准,显示基因型识别灵敏度89.9%、特异度97.1%,疼痛危象识别灵敏度95.1%、特异度96.1%。

要点

  • 基因型识别算法灵敏度89.9%(95%CI 85.1%-93.7%),特异度97.1%(95%CI 92.7%-99.2%)。
  • 基因型算法阳性预测值97.9%(95%CI 94.8%-99.9%),阴性预测值88.7%(95%CI 82.6%-93.3%)。
  • 急性疼痛危象识别灵敏度95.1%(95%CI 86.3%-99.0%),特异度96.1%(95%CI 88.3%-99.6%)。

核心结论

  • 本研究证明在电子健康记录中准确识别特定类型镰状细胞病及疼痛危象是可行的。

研究设计与样本

  • 研究使用2013年至2016年在威斯康星儿童医院接受照护的儿童数据,测试两种算法的准确性。
  • 共纳入360名镰状细胞病患儿,其中51%为女性。
  • 以本地镰状细胞病登记库和患者病历作为金标准。

主要发现

  • 识别血红蛋白SS/Sβ0地中海贫血的算法灵敏度为89.9%(95%CI 85.1%-93.7%),特异度为97.1%(95%CI 92.7%-99.2%)。
  • 该算法阳性预测值为97.9%(95%CI 94.8%-99.9%),阴性预测值为88.7%(95%CI 82.6%-93.3%)。
  • 急性疼痛危象就诊的识别灵敏度为95.1%(95%CI 86.3%-99.0%),特异度为96.1%(95%CI 88.3%-99.6%)。

关键数值与推荐

  • 基因型识别算法采用血液检查结果、经颅多普勒等复合信息联合诊断编码。
  • 急性疼痛就诊通过诊断编码识别,并进一步使用静脉止痛药处方进行细化。
  • 灵敏度和特异度针对上述算法计算,预测值针对基因型识别算法计算。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Electronic health records (EHRs) are a source of big data that provide opportunities for conducting population-based studies and creating learning health systems, especially for rare conditions such as sickle cell disease (SCD). The objective of our study is to validate algorithms for accurate identification of patients with hemoglobin (Hb) SS/Sβ0 thalassemia and acute care encounters for pain among SCD patients within EHR warehouse. We used data for children receiving care at Children's Hospital of Wisconsin from 2013 to 2016 to test the accuracy of the 2 algorithms. The algorithm for genotype identification used composite information (blood test results, transcranial Doppler) along with diagnoses codes. Acute pain encounters were identified using diagnoses codes and further refined by using prescription of IV pain medications. Sensitivities and specificities were calculated for the algorithms. Predictive values for the algorithm to identify SCD genotype were calculated. For all assessments, the local SCD registry and patients' charts were considered gold standards. These included 360 children with SCD, of whom 51% were females. Our algorithm to identify patients with HbSS/Sβ0 thalassemia demonstrated sensitivity of 89.9% (confidence interval [CI], 85.1%-93.7%) and specificity of 97.1% (CI, 92.7%-99.2%). This algorithm had a positive and negative predictive value of 97.9% (CI, 94.8%-99.9%) and 88.7% (CI, 82.6%-93.3%), respectively. Acute pain crises encounters were identified with a sensitivity and specificity of 95.1% (CI, 86.3%-99.0%) and 96.1% (CI, 88.3%-99.6%). This study demonstrates the feasibility to accurately identify patients with specific types of SCD and pain crises within an EHR.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Singh A, Mora J, Panepinto JA, et al. Identification of patients with hemoglobin SS/Sβ0 thalassemia disease and pain crises within electronic health records. Blood Adv. 2018. PMID: 29792312. doi:10.1182/bloodadvances.2018017541

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。